

| 规格 | 价格 | 会员价 | 库存 | 数量 | |||
|---|---|---|---|---|---|---|---|
| {[ item.pr_size ]} {[ size_append(item.pr_size_append, item.pr_am, item.pr_size) ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]} {[ getRatePriceInt(item.pr_rmb_sale, 1,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]} {[ getRatePriceInt(item.pr_rmb,item.pr_rate,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]}{[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} | {[ getRatePrice(item.pr_rmb_sale, 1,1,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate,item.mem_isinteger) ]} | 现货 | 1周 咨询 | - + |
快速发货 顺丰冷链运输,1-2 天到达
品质保证
技术支持
免费溶解

| 描述 | ANA-12 (10 nM) inhibits BDNF-stimulated neurite extension in TrkB-expressing cells and entirely negates BDNF's effects at doses ranging from 10 to 100 μM[1]. |
| 体内研究 | ANA-12 (0.5 mg/kg, i.p.) partially reduces overall endogenous TrkB activity in the mouse brain. When administered to mice, ANA-12 exhibits anxiolytic and antidepressant effects at a dosage of 0.5 mg/kg. ANA-12 (0.5, 1.0, and 2.0 mg/kg) does not impact neuron viability[1]. ANA-12 (0.5 mg/kg) displays antidepressant properties against depression-like behaviors induced by lipopolysaccharide (LPS). ANA-12 (0.5 mg/kg) markedly reduces the prolonged immobility time observed in mice with depression. However, in the Tail Suspension Test (TST), Forced Swim Test (FST), and Sucrose Preference Test (SPT), ANA-12 (0.5 mg/kg) does not exhibit antidepressant-like effects in control mice[2]. ANA-12 (0.5 mg/kg, i.p.) counteracts the reduced self-administration of cocaine in CocSired rats[3]. |
| 体外研究 | ANA-12 (10 nM) inhibits BDNF-stimulated neurite extension in TrkB-expressing cells and entirely negates BDNF's effects at doses ranging from 10 to 100 μM[1]. |
| Administration | Dosage | Frequency | Description | References | ||
| Rats | Cocaine self-administration model | Intraperitoneal injection | 0.5 mg/kg | 4 hours prior to each of 10 daily sessions | ANA-12 administration reversed the diminished self-administration of cocaine in ♂CocSired rats. | Nat Neurosci. 2013 Jan;16(1):42-7 |
| Sprague-Dawley rats | Cyclophosphamide-induced cystitis model | Intraperitoneal injection | 0.5 mg/kg | Every other day for 3 days | ANA-12 could attenuate mechanical allodynia, restrain activation of astrocytes and microglia and alleviate neuroinflammation. | J Neuroinflammation. 2020 Jan 13;17(1):19 |
| Mice | Early-life stress model | Intraperitoneal injection | 0.5 mg/kg | Single dose | To examine the effects of TrkB receptor inhibition on spatial memory, results showed that ANA-12 significantly decreased preference index, mimicking the cognition-impairing effects of ELS. | Transl Psychiatry. 2023 May 24;13(1):173 |
| Mice | Intracerebral hemorrhage (ICH) | Intraperitoneal injection | 0.5 mg/kg/day | Daily for 7 days, starting 1 day before ICH | To investigate the effects of ANA-12 on WIM after ICH and TrkB activity after ICH. | J Neuroinflammation. 2021 Aug 23;18(1):184 |
| Dose | Mice: 0.5 mg/kg[3] (i.p.) |
| Administration | i.p. |
| 计算器 | ||||
| 存储液制备 | ![]() |
1mg | 5mg | 10mg |
|
1 mM 5 mM 10 mM |
2.45mL 0.49mL 0.25mL |
12.27mL 2.45mL 1.23mL |
24.54mL 4.91mL 2.45mL |
|
| CAS号 | 219766-25-3 |
| 分子式 | C22H21N3O3S |
| 分子量 | 407.49 |
| SMILES Code | O=C(C1=CC2=CC=CC=C2S1)NC3=CC=CC=C3C(NC4C(NCCCC4)=O)=O |
| MDL No. | MFCD00117444 |
| 别名 | |
| 运输 | 蓝冰 |
| InChI Key | TUSCYCAIGRVBMD-UHFFFAOYSA-N |
| Pubchem ID | 2799722 |
| 存储条件 |
In solvent -20°C: 3-6个月 -80°C: 12个月 Pure form Keep in dark place, sealed in dry, 2-8°C |
| 溶解方案 |
DMSO: 15 mg/mL(36.81 mM),配合低频超声,并水浴加热至45℃助溶,注意:DMSO长时间开封后,会吸水并导致溶解能力下降,请避免使用长期开封的DMSO 以下溶解方案都请先按照体外实验的方式配制澄清的储备液,再依次添加助溶剂: ——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议现用现配,当天使用; 以下溶剂前显示的百分比是指该溶剂在终溶液中的体积占比;如在配制过程中出现沉淀、析出现象,可以通过加热和/或超声的方式助溶
|
沪公网安备 31011702889066号
沪ICP备2024050318号-1